Global Opioid Induced Constipation (OIC) Drugs Supply, Demand and Key Producers, 2026-2032
The global Opioid Induced Constipation (OIC) Drugs market size is expected to reach $ 4031 million by 2032, rising at a market growth of 4.5% CAGR during the forecast period (2026-2032).
Opioid Induced Constipation (OIC) refers to constipation symptoms induced by the prolonged use of opioid analgesics such as morphine, fentanyl, and oxycodone. This side effect is particularly common among chronic pain patients and significantly impacts their quality of life. To address this issue, various OIC drugs have been developed, including peripheral µ-opioid receptor antagonists (PAMORAs), prokinetic agents, osmotic or bulk-forming laxatives, stimulant laxatives, and combination therapies. These drugs alleviate or treat constipation symptoms caused by opioid use through different mechanisms of action.In 2024, global Opioid Induced Constipation (OIC) Drugs production reached approximately 277.5 m units , with an average global market price of around US$ 10 perunit.The average gross profit margin of this product is 37%.
The accelerating global aging process and the increasing number of chronic disease patients, especially cancer patients and those undergoing long-term analgesic treatment, have led to a rise in opioid use, thereby increasing the incidence of OIC. Moreover, the growing attention of medical institutions to patients' quality of life has driven the demand for OIC treatment drugs. The development and launch of new drugs, such as Naldemedine, have introduced new treatment options to the market, further promoting its development.
Despite the growing market demand, the high cost of OIC drugs remains a major challenge for patients and healthcare systems. Additionally, some drugs may have side effects, such as diarrhea and nausea, affecting patient compliance. In certain regions, especially in China, treatment options for OIC are limited, primarily relying on adjusting opioid doses or using traditional laxatives, which restricts further market development.
As patients place more emphasis on quality of life, medical institutions' awareness of OIC has increased, driving the use of OIC drugs. Particularly in cancer treatment and chronic pain management, the demand for OIC drugs continues to grow. Furthermore, the increasing demand for personalized treatment has driven the research and application of OIC drugs tailored to different patient groups.
The production of OIC drugs involves various raw materials, including active pharmaceutical ingredients (APIs), excipients, and packaging materials. The production of APIs requires high-purity chemical raw materials and complex synthesis processes to ensure the efficacy and safety of the drugs. Excipients, such as fillers and stabilizers, influence the stability of the drugs and the patient's experience. The choice of packaging materials relates to the storage and transportation conditions of the drugs. Therefore, the quality and supply stability of raw materials are crucial to the production of OIC drugs.
This report studies the global Opioid Induced Constipation (OIC) Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Opioid Induced Constipation (OIC) Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Opioid Induced Constipation (OIC) Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Opioid Induced Constipation (OIC) Drugs total production and demand, 2021-2032, (K Dose)
Global Opioid Induced Constipation (OIC) Drugs total production value, 2021-2032, (USD Million)
Global Opioid Induced Constipation (OIC) Drugs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Opioid Induced Constipation (OIC) Drugs consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Opioid Induced Constipation (OIC) Drugs domestic production, consumption, key domestic manufacturers and share
Global Opioid Induced Constipation (OIC) Drugs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Opioid Induced Constipation (OIC) Drugs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Opioid Induced Constipation (OIC) Drugs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Opioid Induced Constipation (OIC) Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceuticals, Bayer, Sanofi, Mallinckrodt, Salix (Bausch Health), AstraZeneca, Progenics Pharmaceuticals, Purdue Pharm, Nektar Therapeutics, Daiichi Sankyo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Opioid Induced Constipation (OIC) Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Opioid Induced Constipation (OIC) Drugs Market, By Region:
1. How big is the global Opioid Induced Constipation (OIC) Drugs market?
2. What is the demand of the global Opioid Induced Constipation (OIC) Drugs market?
3. What is the year over year growth of the global Opioid Induced Constipation (OIC) Drugs market?
4. What is the production and production value of the global Opioid Induced Constipation (OIC) Drugs market?
5. Who are the key producers in the global Opioid Induced Constipation (OIC) Drugs market?
6. What are the growth factors driving the market demand?
Opioid Induced Constipation (OIC) refers to constipation symptoms induced by the prolonged use of opioid analgesics such as morphine, fentanyl, and oxycodone. This side effect is particularly common among chronic pain patients and significantly impacts their quality of life. To address this issue, various OIC drugs have been developed, including peripheral µ-opioid receptor antagonists (PAMORAs), prokinetic agents, osmotic or bulk-forming laxatives, stimulant laxatives, and combination therapies. These drugs alleviate or treat constipation symptoms caused by opioid use through different mechanisms of action.In 2024, global Opioid Induced Constipation (OIC) Drugs production reached approximately 277.5 m units , with an average global market price of around US$ 10 perunit.The average gross profit margin of this product is 37%.
The accelerating global aging process and the increasing number of chronic disease patients, especially cancer patients and those undergoing long-term analgesic treatment, have led to a rise in opioid use, thereby increasing the incidence of OIC. Moreover, the growing attention of medical institutions to patients' quality of life has driven the demand for OIC treatment drugs. The development and launch of new drugs, such as Naldemedine, have introduced new treatment options to the market, further promoting its development.
Despite the growing market demand, the high cost of OIC drugs remains a major challenge for patients and healthcare systems. Additionally, some drugs may have side effects, such as diarrhea and nausea, affecting patient compliance. In certain regions, especially in China, treatment options for OIC are limited, primarily relying on adjusting opioid doses or using traditional laxatives, which restricts further market development.
As patients place more emphasis on quality of life, medical institutions' awareness of OIC has increased, driving the use of OIC drugs. Particularly in cancer treatment and chronic pain management, the demand for OIC drugs continues to grow. Furthermore, the increasing demand for personalized treatment has driven the research and application of OIC drugs tailored to different patient groups.
The production of OIC drugs involves various raw materials, including active pharmaceutical ingredients (APIs), excipients, and packaging materials. The production of APIs requires high-purity chemical raw materials and complex synthesis processes to ensure the efficacy and safety of the drugs. Excipients, such as fillers and stabilizers, influence the stability of the drugs and the patient's experience. The choice of packaging materials relates to the storage and transportation conditions of the drugs. Therefore, the quality and supply stability of raw materials are crucial to the production of OIC drugs.
This report studies the global Opioid Induced Constipation (OIC) Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Opioid Induced Constipation (OIC) Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Opioid Induced Constipation (OIC) Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Opioid Induced Constipation (OIC) Drugs total production and demand, 2021-2032, (K Dose)
Global Opioid Induced Constipation (OIC) Drugs total production value, 2021-2032, (USD Million)
Global Opioid Induced Constipation (OIC) Drugs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global Opioid Induced Constipation (OIC) Drugs consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: Opioid Induced Constipation (OIC) Drugs domestic production, consumption, key domestic manufacturers and share
Global Opioid Induced Constipation (OIC) Drugs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global Opioid Induced Constipation (OIC) Drugs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global Opioid Induced Constipation (OIC) Drugs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global Opioid Induced Constipation (OIC) Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceuticals, Bayer, Sanofi, Mallinckrodt, Salix (Bausch Health), AstraZeneca, Progenics Pharmaceuticals, Purdue Pharm, Nektar Therapeutics, Daiichi Sankyo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Opioid Induced Constipation (OIC) Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (USD/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Opioid Induced Constipation (OIC) Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Lubiprostone
- Methyl Naltrexone Bromide
- Naldemedine
- Alvimopan
- Others
- Oral Formulations
- Injectable Formulations
- Suppositories / Enemas
- Other
- Peripheral µ-opioid Receptor Antagonists,
- Prokinetic Agents
- Bulk-forming Laxatives
- Other
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Takeda Pharmaceuticals
- Bayer
- Sanofi
- Mallinckrodt
- Salix (Bausch Health)
- AstraZeneca
- Progenics Pharmaceuticals
- Purdue Pharm
- Nektar Therapeutics
- Daiichi Sankyo
- Prestige
- GSK
- Shionogi
- Bausch Health
- Zentiva
- Orifarm A/S
- Viatris
- Endo International
- Zhengdatianqing
1. How big is the global Opioid Induced Constipation (OIC) Drugs market?
2. What is the demand of the global Opioid Induced Constipation (OIC) Drugs market?
3. What is the year over year growth of the global Opioid Induced Constipation (OIC) Drugs market?
4. What is the production and production value of the global Opioid Induced Constipation (OIC) Drugs market?
5. Who are the key producers in the global Opioid Induced Constipation (OIC) Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Opioid Induced Constipation (OIC) Drugs Introduction
1.2 World Opioid Induced Constipation (OIC) Drugs Supply & Forecast
1.2.1 World Opioid Induced Constipation (OIC) Drugs Production Value (2021 & 2025 & 2032)
1.2.2 World Opioid Induced Constipation (OIC) Drugs Production (2021-2032)
1.2.3 World Opioid Induced Constipation (OIC) Drugs Pricing Trends (2021-2032)
1.3 World Opioid Induced Constipation (OIC) Drugs Production by Region (Based on Production Site)
1.3.1 World Opioid Induced Constipation (OIC) Drugs Production Value by Region (2021-2032)
1.3.2 World Opioid Induced Constipation (OIC) Drugs Production by Region (2021-2032)
1.3.3 World Opioid Induced Constipation (OIC) Drugs Average Price by Region (2021-2032)
1.3.4 North America Opioid Induced Constipation (OIC) Drugs Production (2021-2032)
1.3.5 Europe Opioid Induced Constipation (OIC) Drugs Production (2021-2032)
1.3.6 China Opioid Induced Constipation (OIC) Drugs Production (2021-2032)
1.3.7 Japan Opioid Induced Constipation (OIC) Drugs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Opioid Induced Constipation (OIC) Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Opioid Induced Constipation (OIC) Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Opioid Induced Constipation (OIC) Drugs Demand (2021-2032)
2.2 World Opioid Induced Constipation (OIC) Drugs Consumption by Region
2.2.1 World Opioid Induced Constipation (OIC) Drugs Consumption by Region (2021-2026)
2.2.2 World Opioid Induced Constipation (OIC) Drugs Consumption Forecast by Region (2027-2032)
2.3 United States Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.4 China Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.5 Europe Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.6 Japan Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.7 South Korea Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.8 ASEAN Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.9 India Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Opioid Induced Constipation (OIC) Drugs Production Value by Manufacturer (2021-2026)
3.2 World Opioid Induced Constipation (OIC) Drugs Production by Manufacturer (2021-2026)
3.3 World Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturer (2021-2026)
3.4 Opioid Induced Constipation (OIC) Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Opioid Induced Constipation (OIC) Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Opioid Induced Constipation (OIC) Drugs in 2025
3.5.3 Global Concentration Ratios (CR8) for Opioid Induced Constipation (OIC) Drugs in 2025
3.6 Opioid Induced Constipation (OIC) Drugs Market: Overall Company Footprint Analysis
3.6.1 Opioid Induced Constipation (OIC) Drugs Market: Region Footprint
3.6.2 Opioid Induced Constipation (OIC) Drugs Market: Company Product Type Footprint
3.6.3 Opioid Induced Constipation (OIC) Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Value Comparison
4.1.1 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Comparison
4.2.1 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Opioid Induced Constipation (OIC) Drugs Consumption Comparison
4.3.1 United States VS China: Opioid Induced Constipation (OIC) Drugs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Opioid Induced Constipation (OIC) Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Opioid Induced Constipation (OIC) Drugs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value (2021-2026)
4.4.3 United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production (2021-2026)
4.5 China Based Opioid Induced Constipation (OIC) Drugs Manufacturers and Market Share
4.5.1 China Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value (2021-2026)
4.5.3 China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production (2021-2026)
4.6 Rest of World Based Opioid Induced Constipation (OIC) Drugs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Opioid Induced Constipation (OIC) Drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Lubiprostone
5.2.2 Methyl Naltrexone Bromide
5.2.3 Naldemedine
5.2.4 Alvimopan
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Opioid Induced Constipation (OIC) Drugs Production by Type (2021-2032)
5.3.2 World Opioid Induced Constipation (OIC) Drugs Production Value by Type (2021-2032)
5.3.3 World Opioid Induced Constipation (OIC) Drugs Average Price by Type (2021-2032)
6 MARKET ANALYSIS ROUTE OF ADMINISTRATION
6.1 World Opioid Induced Constipation (OIC) Drugs Market Size Overview Route of Administration: 2021 VS 2025 VS 2032
6.2 Segment Introduction Route of Administration
6.2.1 Oral Formulations
6.2.2 Injectable Formulations
6.2.3 Suppositories / Enemas
6.2.4 Other
6.3 Market Segment Route of Administration
6.3.1 World Opioid Induced Constipation (OIC) Drugs Production Route of Administration (2021-2032)
6.3.2 World Opioid Induced Constipation (OIC) Drugs Production Value Route of Administration (2021-2032)
6.3.3 World Opioid Induced Constipation (OIC) Drugs Average Price Route of Administration (2021-2032)
7 MARKET ANALYSIS CHEMICAL CLASS
7.1 World Opioid Induced Constipation (OIC) Drugs Market Size Overview Chemical Class: 2021 VS 2025 VS 2032
7.2 Segment Introduction Chemical Class
7.2.1 Peripheral µ-opioid Receptor Antagonists,
7.2.2 Prokinetic Agents
7.2.3 Bulk-forming Laxatives
7.2.4 Other
7.3 Market Segment Chemical Class
7.3.1 World Opioid Induced Constipation (OIC) Drugs Production Chemical Class (2021-2032)
7.3.2 World Opioid Induced Constipation (OIC) Drugs Production Value Chemical Class (2021-2032)
7.3.3 World Opioid Induced Constipation (OIC) Drugs Average Price Chemical Class (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Opioid Induced Constipation (OIC) Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital Pharmacies
8.2.2 Retail Pharmacies
8.2.3 Online Pharmacies
8.3 Market Segment by Application
8.3.1 World Opioid Induced Constipation (OIC) Drugs Production by Application (2021-2032)
8.3.2 World Opioid Induced Constipation (OIC) Drugs Production Value by Application (2021-2032)
8.3.3 World Opioid Induced Constipation (OIC) Drugs Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Takeda Pharmaceuticals
9.1.1 Takeda Pharmaceuticals Details
9.1.2 Takeda Pharmaceuticals Major Business
9.1.3 Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
9.1.4 Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Takeda Pharmaceuticals Recent Developments/Updates
9.1.6 Takeda Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Bayer
9.2.1 Bayer Details
9.2.2 Bayer Major Business
9.2.3 Bayer Opioid Induced Constipation (OIC) Drugs Product and Services
9.2.4 Bayer Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Bayer Recent Developments/Updates
9.2.6 Bayer Competitive Strengths & Weaknesses
9.3 Sanofi
9.3.1 Sanofi Details
9.3.2 Sanofi Major Business
9.3.3 Sanofi Opioid Induced Constipation (OIC) Drugs Product and Services
9.3.4 Sanofi Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Sanofi Recent Developments/Updates
9.3.6 Sanofi Competitive Strengths & Weaknesses
9.4 Mallinckrodt
9.4.1 Mallinckrodt Details
9.4.2 Mallinckrodt Major Business
9.4.3 Mallinckrodt Opioid Induced Constipation (OIC) Drugs Product and Services
9.4.4 Mallinckrodt Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Mallinckrodt Recent Developments/Updates
9.4.6 Mallinckrodt Competitive Strengths & Weaknesses
9.5 Salix (Bausch Health)
9.5.1 Salix (Bausch Health) Details
9.5.2 Salix (Bausch Health) Major Business
9.5.3 Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Product and Services
9.5.4 Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Salix (Bausch Health) Recent Developments/Updates
9.5.6 Salix (Bausch Health) Competitive Strengths & Weaknesses
9.6 AstraZeneca
9.6.1 AstraZeneca Details
9.6.2 AstraZeneca Major Business
9.6.3 AstraZeneca Opioid Induced Constipation (OIC) Drugs Product and Services
9.6.4 AstraZeneca Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 AstraZeneca Recent Developments/Updates
9.6.6 AstraZeneca Competitive Strengths & Weaknesses
9.7 Progenics Pharmaceuticals
9.7.1 Progenics Pharmaceuticals Details
9.7.2 Progenics Pharmaceuticals Major Business
9.7.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
9.7.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Progenics Pharmaceuticals Recent Developments/Updates
9.7.6 Progenics Pharmaceuticals Competitive Strengths & Weaknesses
9.8 Purdue Pharm
9.8.1 Purdue Pharm Details
9.8.2 Purdue Pharm Major Business
9.8.3 Purdue Pharm Opioid Induced Constipation (OIC) Drugs Product and Services
9.8.4 Purdue Pharm Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Purdue Pharm Recent Developments/Updates
9.8.6 Purdue Pharm Competitive Strengths & Weaknesses
9.9 Nektar Therapeutics
9.9.1 Nektar Therapeutics Details
9.9.2 Nektar Therapeutics Major Business
9.9.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product and Services
9.9.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Nektar Therapeutics Recent Developments/Updates
9.9.6 Nektar Therapeutics Competitive Strengths & Weaknesses
9.10 Daiichi Sankyo
9.10.1 Daiichi Sankyo Details
9.10.2 Daiichi Sankyo Major Business
9.10.3 Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Product and Services
9.10.4 Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Daiichi Sankyo Recent Developments/Updates
9.10.6 Daiichi Sankyo Competitive Strengths & Weaknesses
9.11 Prestige
9.11.1 Prestige Details
9.11.2 Prestige Major Business
9.11.3 Prestige Opioid Induced Constipation (OIC) Drugs Product and Services
9.11.4 Prestige Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Prestige Recent Developments/Updates
9.11.6 Prestige Competitive Strengths & Weaknesses
9.12 GSK
9.12.1 GSK Details
9.12.2 GSK Major Business
9.12.3 GSK Opioid Induced Constipation (OIC) Drugs Product and Services
9.12.4 GSK Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 GSK Recent Developments/Updates
9.12.6 GSK Competitive Strengths & Weaknesses
9.13 Shionogi
9.13.1 Shionogi Details
9.13.2 Shionogi Major Business
9.13.3 Shionogi Opioid Induced Constipation (OIC) Drugs Product and Services
9.13.4 Shionogi Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Shionogi Recent Developments/Updates
9.13.6 Shionogi Competitive Strengths & Weaknesses
9.14 Bausch Health
9.14.1 Bausch Health Details
9.14.2 Bausch Health Major Business
9.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Product and Services
9.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Bausch Health Recent Developments/Updates
9.14.6 Bausch Health Competitive Strengths & Weaknesses
9.15 Zentiva
9.15.1 Zentiva Details
9.15.2 Zentiva Major Business
9.15.3 Zentiva Opioid Induced Constipation (OIC) Drugs Product and Services
9.15.4 Zentiva Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Zentiva Recent Developments/Updates
9.15.6 Zentiva Competitive Strengths & Weaknesses
9.16 Orifarm A/S
9.16.1 Orifarm A/S Details
9.16.2 Orifarm A/S Major Business
9.16.3 Orifarm A/S Opioid Induced Constipation (OIC) Drugs Product and Services
9.16.4 Orifarm A/S Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Orifarm A/S Recent Developments/Updates
9.16.6 Orifarm A/S Competitive Strengths & Weaknesses
9.17 Viatris
9.17.1 Viatris Details
9.17.2 Viatris Major Business
9.17.3 Viatris Opioid Induced Constipation (OIC) Drugs Product and Services
9.17.4 Viatris Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Viatris Recent Developments/Updates
9.17.6 Viatris Competitive Strengths & Weaknesses
9.18 Endo International
9.18.1 Endo International Details
9.18.2 Endo International Major Business
9.18.3 Endo International Opioid Induced Constipation (OIC) Drugs Product and Services
9.18.4 Endo International Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Endo International Recent Developments/Updates
9.18.6 Endo International Competitive Strengths & Weaknesses
9.19 Zhengdatianqing
9.19.1 Zhengdatianqing Details
9.19.2 Zhengdatianqing Major Business
9.19.3 Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Product and Services
9.19.4 Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Zhengdatianqing Recent Developments/Updates
9.19.6 Zhengdatianqing Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Opioid Induced Constipation (OIC) Drugs Industry Chain
10.2 Opioid Induced Constipation (OIC) Drugs Upstream Analysis
10.2.1 Opioid Induced Constipation (OIC) Drugs Core Raw Materials
10.2.2 Main Manufacturers of Opioid Induced Constipation (OIC) Drugs Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Opioid Induced Constipation (OIC) Drugs Production Mode
10.6 Opioid Induced Constipation (OIC) Drugs Procurement Model
10.7 Opioid Induced Constipation (OIC) Drugs Industry Sales Model and Sales Channels
10.7.1 Opioid Induced Constipation (OIC) Drugs Sales Model
10.7.2 Opioid Induced Constipation (OIC) Drugs Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Opioid Induced Constipation (OIC) Drugs Introduction
1.2 World Opioid Induced Constipation (OIC) Drugs Supply & Forecast
1.2.1 World Opioid Induced Constipation (OIC) Drugs Production Value (2021 & 2025 & 2032)
1.2.2 World Opioid Induced Constipation (OIC) Drugs Production (2021-2032)
1.2.3 World Opioid Induced Constipation (OIC) Drugs Pricing Trends (2021-2032)
1.3 World Opioid Induced Constipation (OIC) Drugs Production by Region (Based on Production Site)
1.3.1 World Opioid Induced Constipation (OIC) Drugs Production Value by Region (2021-2032)
1.3.2 World Opioid Induced Constipation (OIC) Drugs Production by Region (2021-2032)
1.3.3 World Opioid Induced Constipation (OIC) Drugs Average Price by Region (2021-2032)
1.3.4 North America Opioid Induced Constipation (OIC) Drugs Production (2021-2032)
1.3.5 Europe Opioid Induced Constipation (OIC) Drugs Production (2021-2032)
1.3.6 China Opioid Induced Constipation (OIC) Drugs Production (2021-2032)
1.3.7 Japan Opioid Induced Constipation (OIC) Drugs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Opioid Induced Constipation (OIC) Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Opioid Induced Constipation (OIC) Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Opioid Induced Constipation (OIC) Drugs Demand (2021-2032)
2.2 World Opioid Induced Constipation (OIC) Drugs Consumption by Region
2.2.1 World Opioid Induced Constipation (OIC) Drugs Consumption by Region (2021-2026)
2.2.2 World Opioid Induced Constipation (OIC) Drugs Consumption Forecast by Region (2027-2032)
2.3 United States Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.4 China Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.5 Europe Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.6 Japan Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.7 South Korea Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.8 ASEAN Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
2.9 India Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Opioid Induced Constipation (OIC) Drugs Production Value by Manufacturer (2021-2026)
3.2 World Opioid Induced Constipation (OIC) Drugs Production by Manufacturer (2021-2026)
3.3 World Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturer (2021-2026)
3.4 Opioid Induced Constipation (OIC) Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Opioid Induced Constipation (OIC) Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Opioid Induced Constipation (OIC) Drugs in 2025
3.5.3 Global Concentration Ratios (CR8) for Opioid Induced Constipation (OIC) Drugs in 2025
3.6 Opioid Induced Constipation (OIC) Drugs Market: Overall Company Footprint Analysis
3.6.1 Opioid Induced Constipation (OIC) Drugs Market: Region Footprint
3.6.2 Opioid Induced Constipation (OIC) Drugs Market: Company Product Type Footprint
3.6.3 Opioid Induced Constipation (OIC) Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Value Comparison
4.1.1 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Comparison
4.2.1 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Opioid Induced Constipation (OIC) Drugs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Opioid Induced Constipation (OIC) Drugs Consumption Comparison
4.3.1 United States VS China: Opioid Induced Constipation (OIC) Drugs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Opioid Induced Constipation (OIC) Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Opioid Induced Constipation (OIC) Drugs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value (2021-2026)
4.4.3 United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production (2021-2026)
4.5 China Based Opioid Induced Constipation (OIC) Drugs Manufacturers and Market Share
4.5.1 China Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value (2021-2026)
4.5.3 China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production (2021-2026)
4.6 Rest of World Based Opioid Induced Constipation (OIC) Drugs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Opioid Induced Constipation (OIC) Drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Lubiprostone
5.2.2 Methyl Naltrexone Bromide
5.2.3 Naldemedine
5.2.4 Alvimopan
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Opioid Induced Constipation (OIC) Drugs Production by Type (2021-2032)
5.3.2 World Opioid Induced Constipation (OIC) Drugs Production Value by Type (2021-2032)
5.3.3 World Opioid Induced Constipation (OIC) Drugs Average Price by Type (2021-2032)
6 MARKET ANALYSIS ROUTE OF ADMINISTRATION
6.1 World Opioid Induced Constipation (OIC) Drugs Market Size Overview Route of Administration: 2021 VS 2025 VS 2032
6.2 Segment Introduction Route of Administration
6.2.1 Oral Formulations
6.2.2 Injectable Formulations
6.2.3 Suppositories / Enemas
6.2.4 Other
6.3 Market Segment Route of Administration
6.3.1 World Opioid Induced Constipation (OIC) Drugs Production Route of Administration (2021-2032)
6.3.2 World Opioid Induced Constipation (OIC) Drugs Production Value Route of Administration (2021-2032)
6.3.3 World Opioid Induced Constipation (OIC) Drugs Average Price Route of Administration (2021-2032)
7 MARKET ANALYSIS CHEMICAL CLASS
7.1 World Opioid Induced Constipation (OIC) Drugs Market Size Overview Chemical Class: 2021 VS 2025 VS 2032
7.2 Segment Introduction Chemical Class
7.2.1 Peripheral µ-opioid Receptor Antagonists,
7.2.2 Prokinetic Agents
7.2.3 Bulk-forming Laxatives
7.2.4 Other
7.3 Market Segment Chemical Class
7.3.1 World Opioid Induced Constipation (OIC) Drugs Production Chemical Class (2021-2032)
7.3.2 World Opioid Induced Constipation (OIC) Drugs Production Value Chemical Class (2021-2032)
7.3.3 World Opioid Induced Constipation (OIC) Drugs Average Price Chemical Class (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Opioid Induced Constipation (OIC) Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital Pharmacies
8.2.2 Retail Pharmacies
8.2.3 Online Pharmacies
8.3 Market Segment by Application
8.3.1 World Opioid Induced Constipation (OIC) Drugs Production by Application (2021-2032)
8.3.2 World Opioid Induced Constipation (OIC) Drugs Production Value by Application (2021-2032)
8.3.3 World Opioid Induced Constipation (OIC) Drugs Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Takeda Pharmaceuticals
9.1.1 Takeda Pharmaceuticals Details
9.1.2 Takeda Pharmaceuticals Major Business
9.1.3 Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
9.1.4 Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Takeda Pharmaceuticals Recent Developments/Updates
9.1.6 Takeda Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Bayer
9.2.1 Bayer Details
9.2.2 Bayer Major Business
9.2.3 Bayer Opioid Induced Constipation (OIC) Drugs Product and Services
9.2.4 Bayer Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Bayer Recent Developments/Updates
9.2.6 Bayer Competitive Strengths & Weaknesses
9.3 Sanofi
9.3.1 Sanofi Details
9.3.2 Sanofi Major Business
9.3.3 Sanofi Opioid Induced Constipation (OIC) Drugs Product and Services
9.3.4 Sanofi Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Sanofi Recent Developments/Updates
9.3.6 Sanofi Competitive Strengths & Weaknesses
9.4 Mallinckrodt
9.4.1 Mallinckrodt Details
9.4.2 Mallinckrodt Major Business
9.4.3 Mallinckrodt Opioid Induced Constipation (OIC) Drugs Product and Services
9.4.4 Mallinckrodt Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Mallinckrodt Recent Developments/Updates
9.4.6 Mallinckrodt Competitive Strengths & Weaknesses
9.5 Salix (Bausch Health)
9.5.1 Salix (Bausch Health) Details
9.5.2 Salix (Bausch Health) Major Business
9.5.3 Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Product and Services
9.5.4 Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Salix (Bausch Health) Recent Developments/Updates
9.5.6 Salix (Bausch Health) Competitive Strengths & Weaknesses
9.6 AstraZeneca
9.6.1 AstraZeneca Details
9.6.2 AstraZeneca Major Business
9.6.3 AstraZeneca Opioid Induced Constipation (OIC) Drugs Product and Services
9.6.4 AstraZeneca Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 AstraZeneca Recent Developments/Updates
9.6.6 AstraZeneca Competitive Strengths & Weaknesses
9.7 Progenics Pharmaceuticals
9.7.1 Progenics Pharmaceuticals Details
9.7.2 Progenics Pharmaceuticals Major Business
9.7.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
9.7.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Progenics Pharmaceuticals Recent Developments/Updates
9.7.6 Progenics Pharmaceuticals Competitive Strengths & Weaknesses
9.8 Purdue Pharm
9.8.1 Purdue Pharm Details
9.8.2 Purdue Pharm Major Business
9.8.3 Purdue Pharm Opioid Induced Constipation (OIC) Drugs Product and Services
9.8.4 Purdue Pharm Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Purdue Pharm Recent Developments/Updates
9.8.6 Purdue Pharm Competitive Strengths & Weaknesses
9.9 Nektar Therapeutics
9.9.1 Nektar Therapeutics Details
9.9.2 Nektar Therapeutics Major Business
9.9.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product and Services
9.9.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Nektar Therapeutics Recent Developments/Updates
9.9.6 Nektar Therapeutics Competitive Strengths & Weaknesses
9.10 Daiichi Sankyo
9.10.1 Daiichi Sankyo Details
9.10.2 Daiichi Sankyo Major Business
9.10.3 Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Product and Services
9.10.4 Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Daiichi Sankyo Recent Developments/Updates
9.10.6 Daiichi Sankyo Competitive Strengths & Weaknesses
9.11 Prestige
9.11.1 Prestige Details
9.11.2 Prestige Major Business
9.11.3 Prestige Opioid Induced Constipation (OIC) Drugs Product and Services
9.11.4 Prestige Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Prestige Recent Developments/Updates
9.11.6 Prestige Competitive Strengths & Weaknesses
9.12 GSK
9.12.1 GSK Details
9.12.2 GSK Major Business
9.12.3 GSK Opioid Induced Constipation (OIC) Drugs Product and Services
9.12.4 GSK Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 GSK Recent Developments/Updates
9.12.6 GSK Competitive Strengths & Weaknesses
9.13 Shionogi
9.13.1 Shionogi Details
9.13.2 Shionogi Major Business
9.13.3 Shionogi Opioid Induced Constipation (OIC) Drugs Product and Services
9.13.4 Shionogi Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Shionogi Recent Developments/Updates
9.13.6 Shionogi Competitive Strengths & Weaknesses
9.14 Bausch Health
9.14.1 Bausch Health Details
9.14.2 Bausch Health Major Business
9.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Product and Services
9.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Bausch Health Recent Developments/Updates
9.14.6 Bausch Health Competitive Strengths & Weaknesses
9.15 Zentiva
9.15.1 Zentiva Details
9.15.2 Zentiva Major Business
9.15.3 Zentiva Opioid Induced Constipation (OIC) Drugs Product and Services
9.15.4 Zentiva Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Zentiva Recent Developments/Updates
9.15.6 Zentiva Competitive Strengths & Weaknesses
9.16 Orifarm A/S
9.16.1 Orifarm A/S Details
9.16.2 Orifarm A/S Major Business
9.16.3 Orifarm A/S Opioid Induced Constipation (OIC) Drugs Product and Services
9.16.4 Orifarm A/S Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Orifarm A/S Recent Developments/Updates
9.16.6 Orifarm A/S Competitive Strengths & Weaknesses
9.17 Viatris
9.17.1 Viatris Details
9.17.2 Viatris Major Business
9.17.3 Viatris Opioid Induced Constipation (OIC) Drugs Product and Services
9.17.4 Viatris Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Viatris Recent Developments/Updates
9.17.6 Viatris Competitive Strengths & Weaknesses
9.18 Endo International
9.18.1 Endo International Details
9.18.2 Endo International Major Business
9.18.3 Endo International Opioid Induced Constipation (OIC) Drugs Product and Services
9.18.4 Endo International Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.18.5 Endo International Recent Developments/Updates
9.18.6 Endo International Competitive Strengths & Weaknesses
9.19 Zhengdatianqing
9.19.1 Zhengdatianqing Details
9.19.2 Zhengdatianqing Major Business
9.19.3 Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Product and Services
9.19.4 Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.19.5 Zhengdatianqing Recent Developments/Updates
9.19.6 Zhengdatianqing Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Opioid Induced Constipation (OIC) Drugs Industry Chain
10.2 Opioid Induced Constipation (OIC) Drugs Upstream Analysis
10.2.1 Opioid Induced Constipation (OIC) Drugs Core Raw Materials
10.2.2 Main Manufacturers of Opioid Induced Constipation (OIC) Drugs Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Opioid Induced Constipation (OIC) Drugs Production Mode
10.6 Opioid Induced Constipation (OIC) Drugs Procurement Model
10.7 Opioid Induced Constipation (OIC) Drugs Industry Sales Model and Sales Channels
10.7.1 Opioid Induced Constipation (OIC) Drugs Sales Model
10.7.2 Opioid Induced Constipation (OIC) Drugs Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Opioid Induced Constipation (OIC) Drugs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Opioid Induced Constipation (OIC) Drugs Production Value by Region (2021-2026) & (USD Million)
Table 3. World Opioid Induced Constipation (OIC) Drugs Production Value by Region (2027-2032) & (USD Million)
Table 4. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Region (2021-2026)
Table 5. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Region (2027-2032)
Table 6. World Opioid Induced Constipation (OIC) Drugs Production by Region (2021-2026) & (K Dose)
Table 7. World Opioid Induced Constipation (OIC) Drugs Production by Region (2027-2032) & (K Dose)
Table 8. World Opioid Induced Constipation (OIC) Drugs Production Market Share by Region (2021-2026)
Table 9. World Opioid Induced Constipation (OIC) Drugs Production Market Share by Region (2027-2032)
Table 10. World Opioid Induced Constipation (OIC) Drugs Average Price by Region (2021-2026) & (USD/Dose)
Table 11. World Opioid Induced Constipation (OIC) Drugs Average Price by Region (2027-2032) & (USD/Dose)
Table 12. Opioid Induced Constipation (OIC) Drugs Major Market Trends
Table 13. World Opioid Induced Constipation (OIC) Drugs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Opioid Induced Constipation (OIC) Drugs Consumption by Region (2021-2026) & (K Dose)
Table 15. World Opioid Induced Constipation (OIC) Drugs Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Opioid Induced Constipation (OIC) Drugs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Opioid Induced Constipation (OIC) Drugs Producers in 2025
Table 18. World Opioid Induced Constipation (OIC) Drugs Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Opioid Induced Constipation (OIC) Drugs Producers in 2025
Table 20. World Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturer (2021-2026) & (USD/Dose)
Table 21. Global Opioid Induced Constipation (OIC) Drugs Company Evaluation Quadrant
Table 22. World Opioid Induced Constipation (OIC) Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Opioid Induced Constipation (OIC) Drugs Production Site of Key Manufacturer
Table 24. Opioid Induced Constipation (OIC) Drugs Market: Company Product Type Footprint
Table 25. Opioid Induced Constipation (OIC) Drugs Market: Company Product Application Footprint
Table 26. Opioid Induced Constipation (OIC) Drugs Competitive Factors
Table 27. Opioid Induced Constipation (OIC) Drugs New Entrant and Capacity Expansion Plans
Table 28. Opioid Induced Constipation (OIC) Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Opioid Induced Constipation (OIC) Drugs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Opioid Induced Constipation (OIC) Drugs Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Opioid Induced Constipation (OIC) Drugs Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share (2021-2026)
Table 37. China Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share (2021-2026)
Table 42. Rest of World Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share (2021-2026)
Table 47. World Opioid Induced Constipation (OIC) Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Opioid Induced Constipation (OIC) Drugs Production by Type (2021-2026) & (K Dose)
Table 49. World Opioid Induced Constipation (OIC) Drugs Production by Type (2027-2032) & (K Dose)
Table 50. World Opioid Induced Constipation (OIC) Drugs Production Value by Type (2021-2026) & (USD Million)
Table 51. World Opioid Induced Constipation (OIC) Drugs Production Value by Type (2027-2032) & (USD Million)
Table 52. World Opioid Induced Constipation (OIC) Drugs Average Price by Type (2021-2026) & (USD/Dose)
Table 53. World Opioid Induced Constipation (OIC) Drugs Average Price by Type (2027-2032) & (USD/Dose)
Table 54. World Opioid Induced Constipation (OIC) Drugs Production Value Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 55. World Opioid Induced Constipation (OIC) Drugs Production Route of Administration (2021-2026) & (K Dose)
Table 56. World Opioid Induced Constipation (OIC) Drugs Production Route of Administration (2027-2032) & (K Dose)
Table 57. World Opioid Induced Constipation (OIC) Drugs Production Value Route of Administration (2021-2026) & (USD Million)
Table 58. World Opioid Induced Constipation (OIC) Drugs Production Value Route of Administration (2027-2032) & (USD Million)
Table 59. World Opioid Induced Constipation (OIC) Drugs Average Price Route of Administration (2021-2026) & (USD/Dose)
Table 60. World Opioid Induced Constipation (OIC) Drugs Average Price Route of Administration (2027-2032) & (USD/Dose)
Table 61. World Opioid Induced Constipation (OIC) Drugs Production Value Chemical Class, (USD Million), 2021 & 2025 & 2032
Table 62. World Opioid Induced Constipation (OIC) Drugs Production Chemical Class (2021-2026) & (K Dose)
Table 63. World Opioid Induced Constipation (OIC) Drugs Production Chemical Class (2027-2032) & (K Dose)
Table 64. World Opioid Induced Constipation (OIC) Drugs Production Value Chemical Class (2021-2026) & (USD Million)
Table 65. World Opioid Induced Constipation (OIC) Drugs Production Value Chemical Class (2027-2032) & (USD Million)
Table 66. World Opioid Induced Constipation (OIC) Drugs Average Price Chemical Class (2021-2026) & (USD/Dose)
Table 67. World Opioid Induced Constipation (OIC) Drugs Average Price Chemical Class (2027-2032) & (USD/Dose)
Table 68. World Opioid Induced Constipation (OIC) Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Opioid Induced Constipation (OIC) Drugs Production by Application (2021-2026) & (K Dose)
Table 70. World Opioid Induced Constipation (OIC) Drugs Production by Application (2027-2032) & (K Dose)
Table 71. World Opioid Induced Constipation (OIC) Drugs Production Value by Application (2021-2026) & (USD Million)
Table 72. World Opioid Induced Constipation (OIC) Drugs Production Value by Application (2027-2032) & (USD Million)
Table 73. World Opioid Induced Constipation (OIC) Drugs Average Price by Application (2021-2026) & (USD/Dose)
Table 74. World Opioid Induced Constipation (OIC) Drugs Average Price by Application (2027-2032) & (USD/Dose)
Table 75. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Takeda Pharmaceuticals Major Business
Table 77. Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
Table 78. Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Takeda Pharmaceuticals Recent Developments/Updates
Table 80. Takeda Pharmaceuticals Competitive Strengths & Weaknesses
Table 81. Bayer Basic Information, Manufacturing Base and Competitors
Table 82. Bayer Major Business
Table 83. Bayer Opioid Induced Constipation (OIC) Drugs Product and Services
Table 84. Bayer Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Bayer Recent Developments/Updates
Table 86. Bayer Competitive Strengths & Weaknesses
Table 87. Sanofi Basic Information, Manufacturing Base and Competitors
Table 88. Sanofi Major Business
Table 89. Sanofi Opioid Induced Constipation (OIC) Drugs Product and Services
Table 90. Sanofi Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Sanofi Recent Developments/Updates
Table 92. Sanofi Competitive Strengths & Weaknesses
Table 93. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 94. Mallinckrodt Major Business
Table 95. Mallinckrodt Opioid Induced Constipation (OIC) Drugs Product and Services
Table 96. Mallinckrodt Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Mallinckrodt Recent Developments/Updates
Table 98. Mallinckrodt Competitive Strengths & Weaknesses
Table 99. Salix (Bausch Health) Basic Information, Manufacturing Base and Competitors
Table 100. Salix (Bausch Health) Major Business
Table 101. Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Product and Services
Table 102. Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Salix (Bausch Health) Recent Developments/Updates
Table 104. Salix (Bausch Health) Competitive Strengths & Weaknesses
Table 105. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 106. AstraZeneca Major Business
Table 107. AstraZeneca Opioid Induced Constipation (OIC) Drugs Product and Services
Table 108. AstraZeneca Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. AstraZeneca Recent Developments/Updates
Table 110. AstraZeneca Competitive Strengths & Weaknesses
Table 111. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 112. Progenics Pharmaceuticals Major Business
Table 113. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
Table 114. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Progenics Pharmaceuticals Recent Developments/Updates
Table 116. Progenics Pharmaceuticals Competitive Strengths & Weaknesses
Table 117. Purdue Pharm Basic Information, Manufacturing Base and Competitors
Table 118. Purdue Pharm Major Business
Table 119. Purdue Pharm Opioid Induced Constipation (OIC) Drugs Product and Services
Table 120. Purdue Pharm Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Purdue Pharm Recent Developments/Updates
Table 122. Purdue Pharm Competitive Strengths & Weaknesses
Table 123. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table 124. Nektar Therapeutics Major Business
Table 125. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product and Services
Table 126. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Nektar Therapeutics Recent Developments/Updates
Table 128. Nektar Therapeutics Competitive Strengths & Weaknesses
Table 129. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 130. Daiichi Sankyo Major Business
Table 131. Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Product and Services
Table 132. Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Daiichi Sankyo Recent Developments/Updates
Table 134. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 135. Prestige Basic Information, Manufacturing Base and Competitors
Table 136. Prestige Major Business
Table 137. Prestige Opioid Induced Constipation (OIC) Drugs Product and Services
Table 138. Prestige Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Prestige Recent Developments/Updates
Table 140. Prestige Competitive Strengths & Weaknesses
Table 141. GSK Basic Information, Manufacturing Base and Competitors
Table 142. GSK Major Business
Table 143. GSK Opioid Induced Constipation (OIC) Drugs Product and Services
Table 144. GSK Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. GSK Recent Developments/Updates
Table 146. GSK Competitive Strengths & Weaknesses
Table 147. Shionogi Basic Information, Manufacturing Base and Competitors
Table 148. Shionogi Major Business
Table 149. Shionogi Opioid Induced Constipation (OIC) Drugs Product and Services
Table 150. Shionogi Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Shionogi Recent Developments/Updates
Table 152. Shionogi Competitive Strengths & Weaknesses
Table 153. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 154. Bausch Health Major Business
Table 155. Bausch Health Opioid Induced Constipation (OIC) Drugs Product and Services
Table 156. Bausch Health Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Bausch Health Recent Developments/Updates
Table 158. Bausch Health Competitive Strengths & Weaknesses
Table 159. Zentiva Basic Information, Manufacturing Base and Competitors
Table 160. Zentiva Major Business
Table 161. Zentiva Opioid Induced Constipation (OIC) Drugs Product and Services
Table 162. Zentiva Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Zentiva Recent Developments/Updates
Table 164. Zentiva Competitive Strengths & Weaknesses
Table 165. Orifarm A/S Basic Information, Manufacturing Base and Competitors
Table 166. Orifarm A/S Major Business
Table 167. Orifarm A/S Opioid Induced Constipation (OIC) Drugs Product and Services
Table 168. Orifarm A/S Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Orifarm A/S Recent Developments/Updates
Table 170. Orifarm A/S Competitive Strengths & Weaknesses
Table 171. Viatris Basic Information, Manufacturing Base and Competitors
Table 172. Viatris Major Business
Table 173. Viatris Opioid Induced Constipation (OIC) Drugs Product and Services
Table 174. Viatris Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Viatris Recent Developments/Updates
Table 176. Viatris Competitive Strengths & Weaknesses
Table 177. Endo International Basic Information, Manufacturing Base and Competitors
Table 178. Endo International Major Business
Table 179. Endo International Opioid Induced Constipation (OIC) Drugs Product and Services
Table 180. Endo International Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Endo International Recent Developments/Updates
Table 182. Endo International Competitive Strengths & Weaknesses
Table 183. Zhengdatianqing Basic Information, Manufacturing Base and Competitors
Table 184. Zhengdatianqing Major Business
Table 185. Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Product and Services
Table 186. Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Zhengdatianqing Recent Developments/Updates
Table 188. Zhengdatianqing Competitive Strengths & Weaknesses
Table 189. Global Key Players of Opioid Induced Constipation (OIC) Drugs Upstream (Raw Materials)
Table 190. Global Opioid Induced Constipation (OIC) Drugs Typical Customers
Table 191. Opioid Induced Constipation (OIC) Drugs Typical Distributors
Table 1. World Opioid Induced Constipation (OIC) Drugs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Opioid Induced Constipation (OIC) Drugs Production Value by Region (2021-2026) & (USD Million)
Table 3. World Opioid Induced Constipation (OIC) Drugs Production Value by Region (2027-2032) & (USD Million)
Table 4. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Region (2021-2026)
Table 5. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Region (2027-2032)
Table 6. World Opioid Induced Constipation (OIC) Drugs Production by Region (2021-2026) & (K Dose)
Table 7. World Opioid Induced Constipation (OIC) Drugs Production by Region (2027-2032) & (K Dose)
Table 8. World Opioid Induced Constipation (OIC) Drugs Production Market Share by Region (2021-2026)
Table 9. World Opioid Induced Constipation (OIC) Drugs Production Market Share by Region (2027-2032)
Table 10. World Opioid Induced Constipation (OIC) Drugs Average Price by Region (2021-2026) & (USD/Dose)
Table 11. World Opioid Induced Constipation (OIC) Drugs Average Price by Region (2027-2032) & (USD/Dose)
Table 12. Opioid Induced Constipation (OIC) Drugs Major Market Trends
Table 13. World Opioid Induced Constipation (OIC) Drugs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World Opioid Induced Constipation (OIC) Drugs Consumption by Region (2021-2026) & (K Dose)
Table 15. World Opioid Induced Constipation (OIC) Drugs Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World Opioid Induced Constipation (OIC) Drugs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Opioid Induced Constipation (OIC) Drugs Producers in 2025
Table 18. World Opioid Induced Constipation (OIC) Drugs Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key Opioid Induced Constipation (OIC) Drugs Producers in 2025
Table 20. World Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturer (2021-2026) & (USD/Dose)
Table 21. Global Opioid Induced Constipation (OIC) Drugs Company Evaluation Quadrant
Table 22. World Opioid Induced Constipation (OIC) Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Opioid Induced Constipation (OIC) Drugs Production Site of Key Manufacturer
Table 24. Opioid Induced Constipation (OIC) Drugs Market: Company Product Type Footprint
Table 25. Opioid Induced Constipation (OIC) Drugs Market: Company Product Application Footprint
Table 26. Opioid Induced Constipation (OIC) Drugs Competitive Factors
Table 27. Opioid Induced Constipation (OIC) Drugs New Entrant and Capacity Expansion Plans
Table 28. Opioid Induced Constipation (OIC) Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Opioid Induced Constipation (OIC) Drugs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Opioid Induced Constipation (OIC) Drugs Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China Opioid Induced Constipation (OIC) Drugs Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share (2021-2026)
Table 37. China Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share (2021-2026)
Table 42. Rest of World Based Opioid Induced Constipation (OIC) Drugs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share (2021-2026)
Table 47. World Opioid Induced Constipation (OIC) Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Opioid Induced Constipation (OIC) Drugs Production by Type (2021-2026) & (K Dose)
Table 49. World Opioid Induced Constipation (OIC) Drugs Production by Type (2027-2032) & (K Dose)
Table 50. World Opioid Induced Constipation (OIC) Drugs Production Value by Type (2021-2026) & (USD Million)
Table 51. World Opioid Induced Constipation (OIC) Drugs Production Value by Type (2027-2032) & (USD Million)
Table 52. World Opioid Induced Constipation (OIC) Drugs Average Price by Type (2021-2026) & (USD/Dose)
Table 53. World Opioid Induced Constipation (OIC) Drugs Average Price by Type (2027-2032) & (USD/Dose)
Table 54. World Opioid Induced Constipation (OIC) Drugs Production Value Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 55. World Opioid Induced Constipation (OIC) Drugs Production Route of Administration (2021-2026) & (K Dose)
Table 56. World Opioid Induced Constipation (OIC) Drugs Production Route of Administration (2027-2032) & (K Dose)
Table 57. World Opioid Induced Constipation (OIC) Drugs Production Value Route of Administration (2021-2026) & (USD Million)
Table 58. World Opioid Induced Constipation (OIC) Drugs Production Value Route of Administration (2027-2032) & (USD Million)
Table 59. World Opioid Induced Constipation (OIC) Drugs Average Price Route of Administration (2021-2026) & (USD/Dose)
Table 60. World Opioid Induced Constipation (OIC) Drugs Average Price Route of Administration (2027-2032) & (USD/Dose)
Table 61. World Opioid Induced Constipation (OIC) Drugs Production Value Chemical Class, (USD Million), 2021 & 2025 & 2032
Table 62. World Opioid Induced Constipation (OIC) Drugs Production Chemical Class (2021-2026) & (K Dose)
Table 63. World Opioid Induced Constipation (OIC) Drugs Production Chemical Class (2027-2032) & (K Dose)
Table 64. World Opioid Induced Constipation (OIC) Drugs Production Value Chemical Class (2021-2026) & (USD Million)
Table 65. World Opioid Induced Constipation (OIC) Drugs Production Value Chemical Class (2027-2032) & (USD Million)
Table 66. World Opioid Induced Constipation (OIC) Drugs Average Price Chemical Class (2021-2026) & (USD/Dose)
Table 67. World Opioid Induced Constipation (OIC) Drugs Average Price Chemical Class (2027-2032) & (USD/Dose)
Table 68. World Opioid Induced Constipation (OIC) Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Opioid Induced Constipation (OIC) Drugs Production by Application (2021-2026) & (K Dose)
Table 70. World Opioid Induced Constipation (OIC) Drugs Production by Application (2027-2032) & (K Dose)
Table 71. World Opioid Induced Constipation (OIC) Drugs Production Value by Application (2021-2026) & (USD Million)
Table 72. World Opioid Induced Constipation (OIC) Drugs Production Value by Application (2027-2032) & (USD Million)
Table 73. World Opioid Induced Constipation (OIC) Drugs Average Price by Application (2021-2026) & (USD/Dose)
Table 74. World Opioid Induced Constipation (OIC) Drugs Average Price by Application (2027-2032) & (USD/Dose)
Table 75. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Takeda Pharmaceuticals Major Business
Table 77. Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
Table 78. Takeda Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Takeda Pharmaceuticals Recent Developments/Updates
Table 80. Takeda Pharmaceuticals Competitive Strengths & Weaknesses
Table 81. Bayer Basic Information, Manufacturing Base and Competitors
Table 82. Bayer Major Business
Table 83. Bayer Opioid Induced Constipation (OIC) Drugs Product and Services
Table 84. Bayer Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Bayer Recent Developments/Updates
Table 86. Bayer Competitive Strengths & Weaknesses
Table 87. Sanofi Basic Information, Manufacturing Base and Competitors
Table 88. Sanofi Major Business
Table 89. Sanofi Opioid Induced Constipation (OIC) Drugs Product and Services
Table 90. Sanofi Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Sanofi Recent Developments/Updates
Table 92. Sanofi Competitive Strengths & Weaknesses
Table 93. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 94. Mallinckrodt Major Business
Table 95. Mallinckrodt Opioid Induced Constipation (OIC) Drugs Product and Services
Table 96. Mallinckrodt Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Mallinckrodt Recent Developments/Updates
Table 98. Mallinckrodt Competitive Strengths & Weaknesses
Table 99. Salix (Bausch Health) Basic Information, Manufacturing Base and Competitors
Table 100. Salix (Bausch Health) Major Business
Table 101. Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Product and Services
Table 102. Salix (Bausch Health) Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Salix (Bausch Health) Recent Developments/Updates
Table 104. Salix (Bausch Health) Competitive Strengths & Weaknesses
Table 105. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 106. AstraZeneca Major Business
Table 107. AstraZeneca Opioid Induced Constipation (OIC) Drugs Product and Services
Table 108. AstraZeneca Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. AstraZeneca Recent Developments/Updates
Table 110. AstraZeneca Competitive Strengths & Weaknesses
Table 111. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 112. Progenics Pharmaceuticals Major Business
Table 113. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product and Services
Table 114. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Progenics Pharmaceuticals Recent Developments/Updates
Table 116. Progenics Pharmaceuticals Competitive Strengths & Weaknesses
Table 117. Purdue Pharm Basic Information, Manufacturing Base and Competitors
Table 118. Purdue Pharm Major Business
Table 119. Purdue Pharm Opioid Induced Constipation (OIC) Drugs Product and Services
Table 120. Purdue Pharm Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Purdue Pharm Recent Developments/Updates
Table 122. Purdue Pharm Competitive Strengths & Weaknesses
Table 123. Nektar Therapeutics Basic Information, Manufacturing Base and Competitors
Table 124. Nektar Therapeutics Major Business
Table 125. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product and Services
Table 126. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Nektar Therapeutics Recent Developments/Updates
Table 128. Nektar Therapeutics Competitive Strengths & Weaknesses
Table 129. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 130. Daiichi Sankyo Major Business
Table 131. Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Product and Services
Table 132. Daiichi Sankyo Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Daiichi Sankyo Recent Developments/Updates
Table 134. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 135. Prestige Basic Information, Manufacturing Base and Competitors
Table 136. Prestige Major Business
Table 137. Prestige Opioid Induced Constipation (OIC) Drugs Product and Services
Table 138. Prestige Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Prestige Recent Developments/Updates
Table 140. Prestige Competitive Strengths & Weaknesses
Table 141. GSK Basic Information, Manufacturing Base and Competitors
Table 142. GSK Major Business
Table 143. GSK Opioid Induced Constipation (OIC) Drugs Product and Services
Table 144. GSK Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. GSK Recent Developments/Updates
Table 146. GSK Competitive Strengths & Weaknesses
Table 147. Shionogi Basic Information, Manufacturing Base and Competitors
Table 148. Shionogi Major Business
Table 149. Shionogi Opioid Induced Constipation (OIC) Drugs Product and Services
Table 150. Shionogi Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Shionogi Recent Developments/Updates
Table 152. Shionogi Competitive Strengths & Weaknesses
Table 153. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 154. Bausch Health Major Business
Table 155. Bausch Health Opioid Induced Constipation (OIC) Drugs Product and Services
Table 156. Bausch Health Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Bausch Health Recent Developments/Updates
Table 158. Bausch Health Competitive Strengths & Weaknesses
Table 159. Zentiva Basic Information, Manufacturing Base and Competitors
Table 160. Zentiva Major Business
Table 161. Zentiva Opioid Induced Constipation (OIC) Drugs Product and Services
Table 162. Zentiva Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Zentiva Recent Developments/Updates
Table 164. Zentiva Competitive Strengths & Weaknesses
Table 165. Orifarm A/S Basic Information, Manufacturing Base and Competitors
Table 166. Orifarm A/S Major Business
Table 167. Orifarm A/S Opioid Induced Constipation (OIC) Drugs Product and Services
Table 168. Orifarm A/S Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Orifarm A/S Recent Developments/Updates
Table 170. Orifarm A/S Competitive Strengths & Weaknesses
Table 171. Viatris Basic Information, Manufacturing Base and Competitors
Table 172. Viatris Major Business
Table 173. Viatris Opioid Induced Constipation (OIC) Drugs Product and Services
Table 174. Viatris Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Viatris Recent Developments/Updates
Table 176. Viatris Competitive Strengths & Weaknesses
Table 177. Endo International Basic Information, Manufacturing Base and Competitors
Table 178. Endo International Major Business
Table 179. Endo International Opioid Induced Constipation (OIC) Drugs Product and Services
Table 180. Endo International Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 181. Endo International Recent Developments/Updates
Table 182. Endo International Competitive Strengths & Weaknesses
Table 183. Zhengdatianqing Basic Information, Manufacturing Base and Competitors
Table 184. Zhengdatianqing Major Business
Table 185. Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Product and Services
Table 186. Zhengdatianqing Opioid Induced Constipation (OIC) Drugs Production (K Dose), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 187. Zhengdatianqing Recent Developments/Updates
Table 188. Zhengdatianqing Competitive Strengths & Weaknesses
Table 189. Global Key Players of Opioid Induced Constipation (OIC) Drugs Upstream (Raw Materials)
Table 190. Global Opioid Induced Constipation (OIC) Drugs Typical Customers
Table 191. Opioid Induced Constipation (OIC) Drugs Typical Distributors
LIST OF FIGURES
Figure 1. Opioid Induced Constipation (OIC) Drugs Picture
Figure 2. World Opioid Induced Constipation (OIC) Drugs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Opioid Induced Constipation (OIC) Drugs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Opioid Induced Constipation (OIC) Drugs Production (2021-2032) & (K Dose)
Figure 5. World Opioid Induced Constipation (OIC) Drugs Average Price (2021-2032) & (USD/Dose)
Figure 6. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Region (2021-2032)
Figure 7. World Opioid Induced Constipation (OIC) Drugs Production Market Share by Region (2021-2032)
Figure 8. North America Opioid Induced Constipation (OIC) Drugs Production (2021-2032) & (K Dose)
Figure 9. Europe Opioid Induced Constipation (OIC) Drugs Production (2021-2032) & (K Dose)
Figure 10. China Opioid Induced Constipation (OIC) Drugs Production (2021-2032) & (K Dose)
Figure 11. Japan Opioid Induced Constipation (OIC) Drugs Production (2021-2032) & (K Dose)
Figure 12. Opioid Induced Constipation (OIC) Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 15. World Opioid Induced Constipation (OIC) Drugs Consumption Market Share by Region (2021-2032)
Figure 16. United States Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 17. China Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 18. Europe Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 19. Japan Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 22. India Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Opioid Induced Constipation (OIC) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Opioid Induced Constipation (OIC) Drugs Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Opioid Induced Constipation (OIC) Drugs Markets in 2025
Figure 26. United States VS China: Opioid Induced Constipation (OIC) Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Opioid Induced Constipation (OIC) Drugs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Opioid Induced Constipation (OIC) Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share 2025
Figure 30. China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share 2025
Figure 32. World Opioid Induced Constipation (OIC) Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Type in 2025
Figure 34. Lubiprostone
Figure 35. Methyl Naltrexone Bromide
Figure 36. Naldemedine
Figure 37. Alvimopan
Figure 38. Others
Figure 39. World Opioid Induced Constipation (OIC) Drugs Production Market Share by Type (2021-2032)
Figure 40. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Type (2021-2032)
Figure 41. World Opioid Induced Constipation (OIC) Drugs Average Price by Type (2021-2032) & (USD/Dose)
Figure 42. World Opioid Induced Constipation (OIC) Drugs Production Value Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 43. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share Route of Administration in 2025
Figure 44. Oral Formulations
Figure 45. Injectable Formulations
Figure 46. Suppositories / Enemas
Figure 47. Other
Figure 48. World Opioid Induced Constipation (OIC) Drugs Production Market Share Route of Administration (2021-2032)
Figure 49. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share Route of Administration (2021-2032)
Figure 50. World Opioid Induced Constipation (OIC) Drugs Average Price Route of Administration (2021-2032) & (USD/Dose)
Figure 51. World Opioid Induced Constipation (OIC) Drugs Production Value Chemical Class, (USD Million), 2021 & 2025 & 2032
Figure 52. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share Chemical Class in 2025
Figure 53. Peripheral µ-opioid Receptor Antagonists,
Figure 54. Prokinetic Agents
Figure 55. Bulk-forming Laxatives
Figure 56. Other
Figure 57. World Opioid Induced Constipation (OIC) Drugs Production Market Share Chemical Class (2021-2032)
Figure 58. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share Chemical Class (2021-2032)
Figure 59. World Opioid Induced Constipation (OIC) Drugs Average Price Chemical Class (2021-2032) & (USD/Dose)
Figure 60. Small Molecule
Figure 61. Peptide
Figure 62. Selective 5-HT4 Receptor Agonist
Figure 63. World Opioid Induced Constipation (OIC) Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 64. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Application in 2025
Figure 65. Hospital Pharmacies
Figure 66. Retail Pharmacies
Figure 67. Online Pharmacies
Figure 68. World Opioid Induced Constipation (OIC) Drugs Production Market Share by Application (2021-2032)
Figure 69. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Application (2021-2032)
Figure 70. World Opioid Induced Constipation (OIC) Drugs Average Price by Application (2021-2032) & (USD/Dose)
Figure 71. Opioid Induced Constipation (OIC) Drugs Industry Chain
Figure 72. Opioid Induced Constipation (OIC) Drugs Procurement Model
Figure 73. Opioid Induced Constipation (OIC) Drugs Sales Model
Figure 74. Opioid Induced Constipation (OIC) Drugs Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Opioid Induced Constipation (OIC) Drugs Picture
Figure 2. World Opioid Induced Constipation (OIC) Drugs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Opioid Induced Constipation (OIC) Drugs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Opioid Induced Constipation (OIC) Drugs Production (2021-2032) & (K Dose)
Figure 5. World Opioid Induced Constipation (OIC) Drugs Average Price (2021-2032) & (USD/Dose)
Figure 6. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Region (2021-2032)
Figure 7. World Opioid Induced Constipation (OIC) Drugs Production Market Share by Region (2021-2032)
Figure 8. North America Opioid Induced Constipation (OIC) Drugs Production (2021-2032) & (K Dose)
Figure 9. Europe Opioid Induced Constipation (OIC) Drugs Production (2021-2032) & (K Dose)
Figure 10. China Opioid Induced Constipation (OIC) Drugs Production (2021-2032) & (K Dose)
Figure 11. Japan Opioid Induced Constipation (OIC) Drugs Production (2021-2032) & (K Dose)
Figure 12. Opioid Induced Constipation (OIC) Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 15. World Opioid Induced Constipation (OIC) Drugs Consumption Market Share by Region (2021-2032)
Figure 16. United States Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 17. China Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 18. Europe Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 19. Japan Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 20. South Korea Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 21. ASEAN Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 22. India Opioid Induced Constipation (OIC) Drugs Consumption (2021-2032) & (K Dose)
Figure 23. Producer Shipments of Opioid Induced Constipation (OIC) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Opioid Induced Constipation (OIC) Drugs Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Opioid Induced Constipation (OIC) Drugs Markets in 2025
Figure 26. United States VS China: Opioid Induced Constipation (OIC) Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Opioid Induced Constipation (OIC) Drugs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Opioid Induced Constipation (OIC) Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share 2025
Figure 30. China Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Opioid Induced Constipation (OIC) Drugs Production Market Share 2025
Figure 32. World Opioid Induced Constipation (OIC) Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Type in 2025
Figure 34. Lubiprostone
Figure 35. Methyl Naltrexone Bromide
Figure 36. Naldemedine
Figure 37. Alvimopan
Figure 38. Others
Figure 39. World Opioid Induced Constipation (OIC) Drugs Production Market Share by Type (2021-2032)
Figure 40. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Type (2021-2032)
Figure 41. World Opioid Induced Constipation (OIC) Drugs Average Price by Type (2021-2032) & (USD/Dose)
Figure 42. World Opioid Induced Constipation (OIC) Drugs Production Value Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 43. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share Route of Administration in 2025
Figure 44. Oral Formulations
Figure 45. Injectable Formulations
Figure 46. Suppositories / Enemas
Figure 47. Other
Figure 48. World Opioid Induced Constipation (OIC) Drugs Production Market Share Route of Administration (2021-2032)
Figure 49. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share Route of Administration (2021-2032)
Figure 50. World Opioid Induced Constipation (OIC) Drugs Average Price Route of Administration (2021-2032) & (USD/Dose)
Figure 51. World Opioid Induced Constipation (OIC) Drugs Production Value Chemical Class, (USD Million), 2021 & 2025 & 2032
Figure 52. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share Chemical Class in 2025
Figure 53. Peripheral µ-opioid Receptor Antagonists,
Figure 54. Prokinetic Agents
Figure 55. Bulk-forming Laxatives
Figure 56. Other
Figure 57. World Opioid Induced Constipation (OIC) Drugs Production Market Share Chemical Class (2021-2032)
Figure 58. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share Chemical Class (2021-2032)
Figure 59. World Opioid Induced Constipation (OIC) Drugs Average Price Chemical Class (2021-2032) & (USD/Dose)
Figure 60. Small Molecule
Figure 61. Peptide
Figure 62. Selective 5-HT4 Receptor Agonist
Figure 63. World Opioid Induced Constipation (OIC) Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 64. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Application in 2025
Figure 65. Hospital Pharmacies
Figure 66. Retail Pharmacies
Figure 67. Online Pharmacies
Figure 68. World Opioid Induced Constipation (OIC) Drugs Production Market Share by Application (2021-2032)
Figure 69. World Opioid Induced Constipation (OIC) Drugs Production Value Market Share by Application (2021-2032)
Figure 70. World Opioid Induced Constipation (OIC) Drugs Average Price by Application (2021-2032) & (USD/Dose)
Figure 71. Opioid Induced Constipation (OIC) Drugs Industry Chain
Figure 72. Opioid Induced Constipation (OIC) Drugs Procurement Model
Figure 73. Opioid Induced Constipation (OIC) Drugs Sales Model
Figure 74. Opioid Induced Constipation (OIC) Drugs Sales Channels, Direct Sales, and Distribution
Figure 75. Methodology
Figure 76. Research Process and Data Source
